story of the week
Effect of Biologic Use on the Risk of Advanced-Stage IBD-Associated Intestinal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The American Journal of Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Biologics on the Risk of Advanced-Stage Inflammatory Bowel Disease-Associated Intestinal Cancer: A Nationwide Study
Am. J. Gastroenterol 2023 Jul 01;118(7)1248-1255, R Seishima, K Okabayashi, H Ikeuchi, M Uchino, K Futami, T Noguchi, H Ohge, Y Iseki, K Watanabe, M Itabashi, K Okamoto, Y Toiyama, T Ogino, M Nakamura, K Yamada, T Wakai, Y Sato, H Kimura, K Takahashi, K Hida, Y Kinugasa, F Ishida, J Okuda, K Daito, F Koyama, H Ueno, T Yamamoto, S Yamamoto, T Hanai, A Maemoto, J Arakaki, K Komori, Y Akagi, D Shida, S Yamaguchi, K Matsuda, K Maeda, T Noake, R Nezu, S Sasaki, J Hasegawa, E Sunami, Y Kanemitsu, K Katsumata, K Uehara, T Kiyomatsu, T Suto, S Kazama, T Yamada, T Goi, S Ishihara, Y Ajioka, K SugiharaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.